Taking painkillers long-term 'triples risk of kidney cancer'
September 13, 2011 – People who take anti inflammatory drugs like ibuprofen for more than a decade are tripling their risk of kidney cancer, say scientists. A study of over 125,000 participants found those who regularly took over the counter anti-inflammatories were 51 per cent more likely to develop the disease. But the researchers found those who used them for over a decade, such as arthritis sufferers, were almost three times more likely to suffer renal cell cancer (RCC), the most common form of kidney cancer.
Read article in the Daily Mail (UK)

Arthritis medication raises risk of developing skin cancer, scientists find
September 8, 2011 – Medicine for rheumatoid arthritis could cause skin cancer, experts said. Sufferers treated with TNF inhibitors, drugs which act on the immune system, were 79% more likely to develop melanoma, a study in France found.
Read article in the Daily Mirror (UK)

Warning over global cancer levels
September 7, 2011 – The number of new cancer cases has increased by 20% in under a decade and now stands at 12 million a year, according to the World Cancer Research Fund. It warns that nearly a quarter of those cases are "preventable".
Read article on the BBC News website (UK)
Comment: The only reason that cancer still remains a death verdict is the billions of dollars pharmaceutical companies earn from producing oncology drugs. Given that these drugs are the largest business segment of the multi-billion dollar global pharmaceutical industry, the question therefore has to be asked: What interest can the ‘Business with Disease’ possibly have in trying to prevent cancer if it earns revenues of over $55 billion every year from the existence of the disease? To learn how cancer can be eradicated naturally, without the use of toxic chemotherapy drugs, click here.

Wave of lawsuits follow warnings that top-selling diabetes drug may raise bladder cancer risk
August 5, 2011 – The maker of the world’s best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals Co. Ltd. halted sales of Actos, its top drug, in Germany and France after pressure from regulators. Since then, both the U.S. Food and Drug Administration and the European Medicines Agency have issued warnings about the cancer risk based on new research, but they have allowed sales to continue.
Read article in the Washington Post (USA)

Cooked green vegetables, dried fruit, legumes, and brown rice associated with fewer colon polyps
August 2, 2011 – Eating legumes at least three times a week and brown rice at least once a week was linked to a reduced risk of colon polyps by 33 percent and 40 percent respectively, according to Loma Linda University research recently published in Nutrition and Cancer. High consumption of cooked green vegetables and dried fruit was also associated with greater protection, the study shows.
Read article at

Lycopene may help prevent prostate cancer in African Americans
July 14, 2011 – Lycopene, a red pigment that gives tomatoes and certain other fruits and vegetables their color, could help prevent prostate cancer, especially in African American men, according to new research at the University of Illinois at Chicago. Lycopene is a potent antioxidant, and some studies have shown that diets rich in tomatoes may lower the risk of certain cancers, especially those of the prostate, lung and stomach.
Read article at

Takeda Pulls Actos In France Over Bladder Cancer
July 11, 2011 – One month after French regulators suspended the use of the Actos diabetes pill after a review of pharmacovigilance data showed an increased risk of bladder cancer, Takeda Pharmaceuticals has withdrawn the drug. The Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) also asked Takeda to withdraw a related brand called Competact. The decision by AFSSAPS was based on a study by a national French insurer and examined nearly 1.5 million people between 40 and 79 years old who were treated between 2006 and 2009 (back story).
Read article at

The healing power of ginger
July 8, 2011 – Ginger is an herb with a complex chemical structure and proven efficacy in treating certain medical conditions. So why don’t we know more about it and use it more often? Actually, many parts of the world have been using this herb for more than 2,000 years — it is a common additive and medicinal herb in Chinese and Indian cultures. Over the last 20 years, numerous studies have shown the efficacy of ginger in treating various conditions. In vitro studies suggest that ginger has antiemetic, anti-inflammatory, and hypoglycemic effects and may additionally protect against Alzheimer’s disease and cancer.
Read article in the Bangor Daily News (Maine, United States)

High folate intake may reduce risk of colorectal cancer
July 5, 2011 – Intake of high levels of folate may reduce colorectal cancer risk, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Folate is a water-soluble B vitamin that occurs naturally in food.
Read article at

Combination of calcium, vitamin D reduces melanoma risks in some women
June 27, 2011 – A combination of calcium and vitamin D may cut the chance of melanoma in half for some women at high risk of developing this life-threatening skin cancer, according to a new study by Stanford University School of Medicine researchers.
Read article at

Diabetes Drug From Bristol Linked To Certain Cancer Types
June 26, 2011 – An experimental diabetes drug from Bristol-Myers Squibb known as dapagliflozin has been found to be linked to certain types of cancers.
Read article at

FDA links some prostate drugs to cancer risk
June 10, 2011 – The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer.
Read Associated Press news report at

Magnesium supplements may ease hot flashes for breast cancer patients
June 7, 2011 – Daily supplements of magnesium may ease hot flashes in women with breast cancer, suggest data from a pilot phase II trial from Virginia Commonwealth University Health System. Writing in Supportive Care in Cancer, scientists report that 400 mg per day of magnesium oxide for 4 weeks was associated with a 41.4 percent reduction in the frequency of hot flashes. The intensity of the hot flashes was also reduced as a result of magnesium supplementation by about 50 percent.
Read article at

Cellphone Radiation May Cause Cancer, Advisory Panel Says
May 31, 2011 – A World Health Organization panel has concluded that cellphones are “possibly carcinogenic,’’ putting the popular devices in the same category as certain dry cleaning chemicals and pesticides, as a potential threat to human health. The finding, from the agency’s International Agency for Research on Cancer, adds to concerns among a small but growing group of experts about the health effects of low levels of radiation emitted by cellphones. The panel, which consisted of 31 scientists from 14 countries, was led by Dr. Jonathan M. Samet, a physician and epidemiologist at the University of Southern California and a member of President Obama’s National Cancer Advisory Board.
Read article in the New York Times (USA)

Chlorine and Childhood Cancer
May 25, 2011 – A significant positive association between the risk of childhood leukemia and levels of chlorine-containing chemicals in the atmosphere has been found by researchers in Portugal. Details are reported in the current issue of the International Journal of Environment and Health.
Read article at

More signs diabetes drug linked to bladder cancer
May 13, 2011 – A review of official reports of bad drug reactions is revealing more signs that people taking the diabetes drug Actos are at higher risk of developing bladder cancer.
Read news report at

'Sunshine vitamin' pills may extend lives of cancer patients
May 12, 2011 – A vitamin pill available for a few pence in any local chemist's shop may have a bigger impact in extending the survival of cancer patients than drugs costing tens of thousands of pounds, says a leading cancer specialist. Professor Angus Dalgeish, consultant medical oncologist at St George's Hospital, Tooting, south-west London, will tell a conference next week that he tests all his cancer patients for the level of Vitamin D and prescribes supplements where they are low. At St George's, where he runs a clinic for patients with melanoma, the deadliest form of skin cancer, tests showed that the majority had low Vitamin D.
Read article in The Independent (UK)

Paracetamol 'link' to blood cancer
May 10, 2011 – Taking paracetamol regularly could almost double the chance of getting a relatively rare form of cancer, research suggests.
Read article in the Daily Telegraph (UK)

Chemo Brain May Last 5 Years or More
May 4, 2011 – “Chemo brain,” the foggy thinking and forgetfulness that cancer patients often complain about after treatment, may last for five years or more for a sizable percentage of patients, new research shows. The findings, based on a study of 92 cancer patients at Fred Hutchinson Cancer Research Center in Seattle, suggest that the cognitive losses that seem to follow many cancer treatments are far more pronounced and longer-lasting than commonly believed. The study, published in The Journal of Clinical Oncology, is a vindication of sorts for many cancer patients, whose complaints about thinking and memory problems are often dismissed by doctors who lay blame for the symptoms on normal aging or the fatigue of illness.
Read article in the New York Times (USA)
Comment: So toxic are some chemotherapy drugs that they are actually listed in the “11th Report on Carcinogens” of the US National Toxicology Program as known carcinogens. In other words, the drugs prescribed to millions of cancer patients as a cure are, in fact, known to cause cancer. To learn more about the dangers of these toxic drugs, and read shocking extracts from their "patient information leaflets", as published by the drug manufacturers themselves, click here.

Aggressive Breast Tumors Linked to Vitamin D Deficiency
April 29, 2011 – Low vitamin D levels among women with breast cancer correlate with more aggressive tumors and poorer prognosis, according to a new University of Rochester Medical Center study highlighted this week at the American Society of Breast Surgeons meeting in Washington, D.C.
Read article on the University of Rochester Medical Center website (USA)

Bowel Drugs Side Effects May Cause Fatal Blood Cancer: FDA Warns
April 19, 2011 – Federal drug regulators are receiving an increasing amount of blood cancer reports from users of some drugs designed to treat inflammatory bowel disease (IBD). The FDA issued a drug safety alert on April 14 for tumor necrosis factor (TNF) blockers, including Cimzia, Enbrel, Humira, Remicade and Simponi, as well as other types of drugs like azathioprine and mercaptopurine. The agency says a number of reports have linked the drugs to a rare cancer of white blood cells in children and young adults known as Hepatosplenic T-Cell Lymphoma (HSTCL).
Read article at (USA)

Mother worried about treatment side effects
Charged in death of son, she says chemo was making boy far sicker than the cancer
April 9, 2011 – First he had a bloated face from the steroids, then dark circles under his eyes. Young Jeremy Fraser would soon become lethargic once his chemotherapy treatment began, his mother said yesterday, and he looked like “he wanted to get out of his own body.’’ “Jeremy went from pretty much being OK, to being hammered on medications that were really making him sick,’’ Kristen LaBrie told a Superior Court jury yesterday, offering her own account of her decision in the treatment of her son. In tones that bounced between conversational and combative, the Beverly mother, charged with the attempted murder of Jeremy, told jurors that she withheld cancer treatment for the boy because side effects from the medication wore on him far worse than his sickness.
Read article in The Boston Globe (USA)
Comment: Cancer is a multi-billion dollar business. The drugs used in chemotherapy do kill cancer cells – but they also kill healthy cells too. This fact alone is bad enough, but it doesn’t stop there. The drugs used in chemotherapy also have side-effects and many cause new cancers and new diseases, thus leading to the use of yet more drugs which in turn have new side effects. It’s a vicious circle and a license to print money for the pharmaceutical industry. As such, when authorities resort to charging a mother with attempted murder – and eventually succeed in securing a conviction – because she objected to the ongoing poisoning of her child with chemotherapy, it’s a clear sign that the pharmaceutical “business with disease” is under threat. To learn the facts about chemotherapy drugs, click here. To learn how cancer can be eradicated naturally, clickhere.

Cancer charity 'tidies' Wikipedia
April 4, 2011 – Cancer Research UK is turning its specialists loose on the internet to get them to tidy up the online encyclopedia - Wikipedia. The charity said many people researching the subject are turning to the website. But it said there were problems with accuracy and clarity on some of the pages.
Read article on the BBC News website (UK)
Comment: Regular visitors to our website will already be aware that the facts aren’t welcome on Wikipedia when you challenge the interests of the multi-billion dollar drug industry. Notably, therefore, close analysis of Cancer Research UK’s latest annual reportreveals that it has a drug development and commercialisation company, Cancer Research Technology Ltd, that has recently formed partnerships with multinational pharmaceutical companies such as AstraZeneca and Cephalon. As such, some may argue that the nature of Cancer Research UK’s relationships with drug companies raises the question as to whether the charity’s “specialists” have perhaps been tasked with ensuring that cancer-related content on Wikipedia downplays the facts about the toxicity of chemotherapy drugs and, in the process, obscures the main principles governing the pharmaceutical “business with disease”.

Lawyers say plant leaked toxic chemical for years
March 29, 2011 – Company officials failed to alert residents and collect data about groundwater, air and soil contaminated with cancer-causing chemicals from a Central California manufacturing plant owned by a former subsidiary of drug maker Merck & Co., lawyers for nearby residents told jurors Tuesday in closing arguments of a lawsuit.
Read article in the San Francisco Chronicle (USA)

Peer Reviewed Publication Supporting Intravenous Vitamin C for Cancer Patients
March 25, 2011 – The Riordan Clinic announced today publication in the Journal of Translational Medicine results of a collaboration between oncologists, alternative medicine practitioners, and basic researchers, which proposes a new use of intravenous vitamin C for treatment of cancer. The paper, available freely online, describes the possibility of using intravenous vitamin C to treat inflammation associated with cancer.
Read press release at

Study: High Doses of Vitamin D May Prevent Cancer
February 28, 2011 – Researchers now say higher levels of vitamin D may be necessary to reduce one's risk of cancer. Scientists at the University of California, San Diego School of Medicine and Creighton University School of Medicine in Omaha just published a new study in the journal Anticancer Research, noting that traditional intakes of the essential vitamin just aren't enough to reach blood levels that can prevent or significantly decrease the risk of breast cancer and several other major diseases.
Read article at

Selenium may reduce prostate cancer markers: Study
February 23, 2011 – Supplementation with selenium glycinate may increase the activities of related plasma enzymes, and reduce the levels of an important marker for the risk of prostate cancer, according to a new study that contradicts current thinking. The research, published in Nutrition Research, suggests that selenium glycinate supplementation gave changes consistent with improved selenium functional status and lowered prostate cancer risk in a group of 30 middle-aged US men.
Read article at

Vitamin D linked to colon cancer protection: Meta-analysis
February 7, 2011 – High blood levels of vitamin D are associated with a reduced risk of colorectal cancer, according to a new meta-analysis of observational studies from an international team of researchers. Analysis of data from nine studies revealed that, for every 10 nanograms per milliliter increase in levels of vitamin D (25-hydroxyvitamin D) the associated risk of colorectal cancer decreased by 15 percent.
Read article at

To boost cancer-fighting benefits, eat broccoli with a side of sprouts
January 31, 2011 – A new University of Illinois study provides convincing evidence that the way you prepare and eat your broccoli matters, and also suggests that pairing broccoli with broccoli sprouts may make the vegetable's anti-cancer effect almost twice as powerful.
Read article in The Independent (UK)

Roche Sued by Patient Claiming Cancer From Pulled Psoriasis Drug Raptiva
January 8, 2011 – Roche Holding AG’s Genentech Inc. was sued by a Texas psoriasis sufferer who alleges he developed lymphoma while taking Raptiva, a drug the company stopped selling in 2009 when studies linked it to a fatal brain infection. Genentech, a unit of Basel, Switzerland-based drugmaker Roche, began a phased withdrawal of Raptiva in April 2009 after three patients taking it were diagnosed in the preceding six-month period with progressive multifocal leukoencephalopathy, or PML, a rare, incurable brain disease. Houston-area psoriasis patient Cary Massa, 51, was diagnosed with classic Hodgkin’s lymphoma in March 2009, after taking Raptiva from February 2006 to January 2008, according to a complaint filed today in Houston federal court.
Read article at